Basic mechanisms of disease progression in the failing heart: The role of excessive adrenergic drive

Progress in Cardiovascular Diseases

Volumn 41, Issue 1 SUPPL., 1998, Pages 1-8

  Mann, D L ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC STIMULATION; CARDIOTOXICITY; CELL FUNCTION; CELLULAR IMMUNITY; CONGESTIVE HEART FAILURE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEMODYNAMICS; HUMAN; PATHOGENESIS; REVIEW;

EID: 0031875199     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-0620(98)80025-X     Document Type: Article

References (33)

1. Packer M The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure J Am Coll Cardiol 20 1992 248 254
2. Opie LH Thandroyen FT Muller C Adrenaline-induced “oxygen-wastage” and enzyme release from working rat heart. Effects of calcium antagonism, beta-blockade, nicotinic acid andcoronary artery ligation J Mol Cell Cardiol 11 1979 1073 1094
3. Cohn JN Levine TB Olivari MT Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 1984 819 823
4. Dietz R Schomig A Strasser R Humoral adaptation mechanisms in heart failure Goodwin JF Hjalmarson A Olsen EG Cardiomyopathy 1981 AB Hassle Molndal, Sweden 128
5. Bristow MR Ginsburg R Minobe W Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts N Engl J Med 307 1982 205 211
6. Bristow MR Kantrowitz NE Ginsburg R Beta-adrenergic function in heart muscle disease and heart failure J Mol Cell Cardiol 17 suppl 2 1985 41 52
7. Petch MC Nayler WG Uptake of catecholamines by human cardiac muscle in vitro Br Heart J 41 1979 336 339
8. Josue O Hypertrophie cardioque caus'ee par l'adrenaline et la toxine typhique C R Soc Biol 63 1907 285 290
9. Rona G Chappel CI Balazs T An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat Arch Pathol 67 1959 99/443 111/455
10. Schwartzman RA Cidlowski JA Apoptosis—The biochemistry and molecular biology of programmed cell death Endocr Rev 14 1993 133 151
11. Buja LM Eigenbrodt ML Eigenbrodt EH Apoptosis and necrosis: Basic types and mechanisms of cell death Arch Pathol Lab Med 117 1993 1208 1214
12. Jalil JE Janicki JS Pick R Fibrosis-induced reduction of endomyocardium in the rat after isoproterenol treatment Circ Res 65 1989 258 264
13. Benjamin IJ Jalil JE Tan LB Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis Circ Res 65 1989 657 670
14. Somani P Laddu AR Hardman HF Nutritional circulation in the heart. III. Effect of isoproterenol and beta-adrenergic blockade on myocardial hemodynamics and rubidium-86 extraction in the isolated supported heart preparation J Pharmacol Exp Ther 175 1970 577 592
15. Rona G Catecholamine cardiotoxicity J Mol Cell Cardiol 17 1985 291 306
16. Rona G Boutet M Hüttner I Membrane permeability alterations as manifestation of early cardiac muscle cell injury Fleckenstein A Rona G Recent Advances in Studies on Cardiac Structure and Metabolism, vol 6, Pathophysiology and Morphology of Myocardial Cell Alteration 1975 University Park Press Baltimore, MD 439 451
17. Fleckenstein A Janke J Doring HJ Ca overload as the determinant factor in the production of catecholamine-induced myocardial lesions Recent Adv Study Card Struct Metabol 2 1973 455 466
18. Bloom S Davis DL Calcium as mediator of isoproterenol-induced myocardial necrosis Am J Pathol 69 1972 459 470
19. Bhagat B Sullivan JM Fischer VW cAMP activity and isoproterenol-induced myocardial injury in rats Kobayashi T Ito Y Rona G Recent Advances in Studies on Cardiac Structure and Metabolism, vol 12, Cardiac Adaptation 1992 University Park Press Baltimore, MD 465 470
20. Opie LH Walpoth B Barsacchi R Calcium and catecholamines: Relevance to cardiomyopathies and significance in therapeutic strategies J Mol Cell Cardiol 17 suppl 2 1985 21 34
21. Wheatley AM Thandroyen FT Opie LH Catecholamine-induced myocardial cell damage: Catecholamines or adrenochrome J Mol Cell Cardiol 17 1985 349 359
22. Downing SE Lee JC Contribution of alpha-adrenoceptor activation to the pathogenesis of norepinephrine cardiomyopathy Circ Res 52 1983 471 478
23. Downing SE Chen V Myocardial injury following endogenous catecholamine release in rabbits J Mol Cell Cardiol 17 1985 377 387
24. Dhalla NS Yates JC Lee SL Functional and subcellular changes in the isolated rat heart perfused with oxidized isoproterenol J Mol Cell Cardiol 10 1978 31 41
25. Singal PK Kapur N Dhillon KS Role of free radicals in catecholamine-induced cardiomyopathy Can J Physiol Pharmacol 60 1982 1390 1397
26. Mann DL Kent RL Parsons B Adrenergic effects on the biology of the adult mammalian cardiocyte Circulation 85 1992 790 804
27. Szakacs JE Cannon A 1-Norepinephrine myocarditis Am J Clin Pathol 30 1958 425 434
28. Lehr D Tissue electrolyte alterations in disseminated myocardial necrosis Ann N Y Acad Sci 156 1969 344 350
29. McConkey DJ Orrenius S The role of calcium in the regulation of apoptosis J Leukoc Biol 59 1996 775 783
30. Lohmann RD Beyersmann D Cadmium- and zinc-mediated changes of the Ca(2+)-dependent endonuclease in apoptosis Biochem Biophys Res Com 190 1993 1097 1103
31. Viviani B Rossi AD Chow SC Organotin compounds induce calcium overload and apoptosis in PC12 cells Neurotoxicology 16 1995 19 25
32. Bristow MR Gilbert EM Improvement in cardiac myocyte function by biological effects of medical therapy: A new concept in the treatment of heart failure Eur Heart J 16 1995 20 31
33. Packer M Bristow MR Cohn JN The effect of carvedilol on morbidity and mortality in patients with chronic heart failure N Engl J Med 334 1996 1350 1355